{"id":13037,"date":"2018-06-14T14:09:00","date_gmt":"2018-06-14T14:09:00","guid":{"rendered":"http:\/\/parkinson-export.local\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/"},"modified":"2018-06-14T14:09:00","modified_gmt":"2018-06-14T18:09:00","slug":"les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint","status":"publish","type":"post","link":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/","title":{"rendered":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d&rsquo;appoint"},"content":{"rendered":"<p>UCB Canada inc. a annonc\u00e9 aujourd&rsquo;hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens.  Bien qu&rsquo;il n&rsquo;existe actuellement pas de traitement curatif pour la MP, certains m\u00e9dicaments peuvent en att\u00e9nuer les sympt\u00f4mes invalidants.<\/p>\n<p><a href=\"https:\/\/www.newswire.ca\/fr\/news-releases\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint-685349131.html\" rel=\"noopener\" target=\"_blank\">Cliquez ici<\/a> pour en savoir plus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UCB Canada inc. a annonc\u00e9 aujourd&rsquo;hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[64],"tags":[],"audience":[],"class_list":["post-13037","post","type-post","status-publish","format-standard","hentry","category-actualites"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/posts\/13037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/comments?post=13037"}],"version-history":[{"count":0,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/posts\/13037\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/media?parent=13037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/categories?post=13037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/tags?post=13037"},{"taxonomy":"audience","embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/audience?post=13037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}